Elevance Health Inc.
ELV | NYSE
$395.95
-$2.61 (-0.65%)
Sep 24, 2026, 2:15 PM ET · Market open
Market Data
Market Cap $86.44B
Enterprise Value $79.85B
Beta 0.70
Average Volume 1.46M
Shares Outstanding (Diluted) 217.9M
Shares Change YoY -3.5%
Institutional Ownership 88.44%
Exchange NYSE
ISIN US0367521038
Price Performance
Price Change 1M -1.0%
Price Change 3M 3.7%
Price Change 6M 35.3%
Price Change YTD 12.4%
Price Change 1Y 25.2%
Price Change 3Y -8.6%
Price Change 5Y 4.4%
1M CAGR (ann.) 2.5%
1Y CAGR (ann.) 27.9%
5Y CAGR (ann.) 2.7%
All-Time CAGR 10.1%
Valuation
PE Ratio 17.69
Forward PE 13.05
PEG Ratio -3.94
Forward PEG -1.88
PS Ratio 0.43
Forward PS 0.40
PB Ratio 1.92
P/FCF Ratio 13.73
P/Adj. FCF Ratio 14.28
P/OCF Ratio 11.62
EV/Sales 0.40
EV/EBIT 11.42
EV/EBITDA 9.97
EV/FCF 12.70
Earnings Yield 5.7%
FCF Yield 7.3%
Adj. FCF Yield 7.0%
Financial Health
Net Cash $6.47B
Total Debt $31.04B
Cash & Short-Term Investments $37.51B
Total Assets $126.44B
Current Ratio 2.05
Quick Ratio 2.05
Debt / Equity Ratio 0.69
Debt / EBITDA 3.88
Debt / FCF 4.94
OCF / Debt 0.24
Interest Coverage 6.25
Altman Z-Score 3.14
Piotroski F-Score 7
Margins & Profitability
Gross Profit Margin 39.0%
Operating Profit Margin 3.5%
EBITDA Margin 4.0%
Net Profit Margin 2.5%
FCF Margin 3.1%
Adj. FCF Margin 3.0%
SBC / Revenue 0.1%
SBC Impact (per share) -3.9%
Returns
Return on Assets 3.9%
Return on Equity 11.2%
Return on Invested Capital 6.3%
Return on Capital Employed 7.5%
Return on Tangible Assets 5.7%
Historical Growth (CAGR)
Revenue CAGR 3Y 6.7%
Revenue CAGR 5Y 9.3%
Revenue CAGR 10Y 9.4%
EPS CAGR 3Y -5.1%
EPS CAGR 5Y 5.7%
EPS CAGR 10Y 10.0%
FCF CAGR 3Y -15.9%
FCF CAGR 5Y 1.7%
FCF CAGR 10Y 9.2%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 38
EPS Growth Next 3Y 21.1%
Revenue Growth Next 3Y 2.1%
Earnings Date Oct 20, 2026
EPS Estimate (next Q) $4.66
EPS Growth Est (next Q) -22.7%
Revenue Est (next Q) $49.3B
Revenue Growth Est (next Q) -1.6%
Fair Value Estimates
Graham Number $323.42
Graham Upside -18.8%
Lynch Fair Value $129.15
Lynch Upside -67.5%
Price Target $444.06
Price Target Upside 11.6%
Cash Flow
Operating Cash Flow $7.46B
Free Cash Flow $6.29B
Adj. Free Cash Flow $6.05B
FCF Per Share $28.86
OCF Per Share $34.25
OCF/S Ratio 3.7%
Income Statement
Revenue $201.11B
Gross Profit $78.34B
Operating Income $7.06B
EBITDA $8.01B
Net Income $4.96B
EPS (Diluted) $22.50
Revenue / Employee $2.08M
Profit / Employee $51.37K
Employees 96,615
Dividends
Annual Dividend $6.87
Dividend Yield 1.73%
Payout Ratio 30.5%
FCF Payout Ratio 24.0%
Adj. FCF Payout Ratio 24.9%
Dividend Growth (YoY) 1.6%
Pay Frequency Quarterly
Ex-Dividend Date Sep 9, 2026
Add to Watchlist
Select watchlists to add or remove ELV